The campaign provided $500 million to go toward research, technology enhancements and faculty recruitment, and another $500 million to invest in facilities and programs to advance brain research and training, UT Southwestern said in a Feb. 16 news release..
“This billion-dollar investment reflects UT Southwestern’s commitment to work at the vanguard of basic scientific and clinical research aimed at understanding brain function, and to uncovering transformational insights for diagnosis and treatment of disorders affecting the brain. Our hope is that one day no patient diagnosed with brain disease will ever hear the words ‘there is no cure,'” Daniel Podolsky, MD, president of UT Southwestern, said in the release.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
